STAT3 and cancer: In accordance, several reports demonstrate that drug-induced modulation of STAT3 activation and its target genes prevent muscle wasting mainly in models of cancer cachexia (Sala et al., 2019) and attenuate denervation induced muscle atrophy (Madaro et al., 2018; Huang et al., 2020) and fibrosis (Madaro et al., 2018).